Journal of Internal Medicine Concepts & Practice ›› 2024, Vol. 19 ›› Issue (06): 379-384.doi: 10.16138/j.1673-6087.2024.06.05
• Original article • Previous Articles Next Articles
HU Jiaqi, JIN Zhengyi, LIU Qilong, JI Lianmei, MA Taiyan, GAO Jie()
Received:
2024-11-04
Online:
2024-12-26
Published:
2025-03-11
CLC Number:
HU Jiaqi, JIN Zhengyi, LIU Qilong, JI Lianmei, MA Taiyan, GAO Jie. Relapsing polychondritis mainly with airway involvement: analysis of clinical characteristics[J]. Journal of Internal Medicine Concepts & Practice, 2024, 19(06): 379-384.
Table 1
Baseline clinical characteristics between the 2 groups [x±s/M(Q1,Q3)/n(%)]
项目 | 总RP患者(n=141) | 气道受累组(n=83) | 非气道受累组(n=58) | t/Z/χ² | P |
---|---|---|---|---|---|
女性[n/(%)] | 69(48.9) | 40(48.2) | 29(50.0) | 0.045 | 0.833 |
起病年龄(岁) | 45.61±5.13 | 45.20±5.13 | 46.19±5.12 | 1.123 | 0.264 |
确诊年龄(岁) | 50.27±5.10 | 51.18±4.85 | 48.97±5.22 | -2.588 | 0.011 |
病程(月) | 9.0(6.5,10.0) | 9.0(7.0,10.0) | 9.0(6.0,10.0) | -1.118 | 0.264 |
耳软骨受累[n(%)] | 64(45.4) | 30(36.1) | 34(58.6) | 6.958 | 0.008 |
鼻受累[n(%)] | 73(51.8) | 44(53.0) | 29(50.0) | 0.124 | 0.725 |
眼部受累[n(%)] | 48(34.0) | 21(25.3) | 27(46.6) | 6.867 | 0.009 |
前庭功能受累[n(%)] | 8(5.7) | 6(7.2) | 2(3.4) | 0.912 | 0.340 |
关节受累[n(%)] | 108(76.6) | 61(73.5) | 47(81.0) | 1.083 | 0.298 |
心血管受累[n(%)] | 50(35.5) | 23(27.7) | 27(46.6) | 5.296 | 0.021 |
肾脏受累[n(%)] | 5(3.5) | 3(3.6) | 2(3.4) | 0.003 | 0.958 |
神经系统受累[n(%)] | 25(17.7) | 14(16.9) | 11(19.0) | 0.103 | 0.748 |
红细胞沉降率(mm/h) | 15.3(12.5,20.0) | 14.5(12.1,19.3) | 17.9(13.58,21.0) | -3.077 | 0.002 |
超敏C反应蛋白(mg/L) | 16.4(13.5,20.4) | 14.8(12.5,20.5) | 18.6(15.3,20.5) | -2.281 | 0.023 |
血红蛋白(g/L) | 112(105.5,121) | 114(110,121) | 107(104,121) | -1.961 | 0.05 |
白细胞计数(×10⁹/L) | 6.86(5.74,9.45) | 6.93(5.78,9.13) | 6.46(5.23,9.63) | -0.633 | 0.527 |
中性粒细胞计数(×10⁹/L) | 5.08±2.27 | 5.46±2.65 | 4.54±1.43 | -2.398 | 0.018 |
血小板计数(×10⁹/L) | 210.6±67.8 | 198.8±61.2 | 227.4±73.6 | 2.515 | 0.013 |
铁蛋白(μg/L) | 142.0(73.0,196.5) | 137.0 (75.0,196.0) | 155.0 (59.0,201.5) | -0.547 | 0.584 |
丙氨酸转氨酶(U/L) | 45.8±9.1 | 44.4±7.3 | 47.7±11.0 | 1.992 | 0.049 |
肌酐(μmol/L) | 84.0 (73.5,95.0) | 84.0(69.0,94.0) | 85.5(74.0,97.5) | -1.717 | 0.086 |
ANA阳性[n(%)] | 29(20.6) | 18(21.7) | 11(19.0) | 0.155 | 0.694 |
ANCA阳性[n(%)] | 16(11.3) | 8(9.6) | 8(13.8) | 0.586 | 0.444 |
Table 2
Univariate Logistic regression was used to analyze the risk factors associated with airway involvement among clinical variables
项目 | OR(95%CI) | P |
---|---|---|
女性 | 0.931 (0.478~1.813) | 0.833 |
起病年龄 | 0.963 (0.901~1.030) | 0.264 |
确诊年龄 | 1.089 (1.020~1.163) | 0.011 |
病程 | 0.963 (0.901~1.030) | 0.264 |
耳软骨受累 | 0.398 (0.201~0.789) | 0.008 |
鼻受累 | 1.127 (0.579~2.196) | 0.725 |
眼部受累 | 0.389 (0.191~0.793) | 0.009 |
前庭功能受累 | 2.167 (0.416~11.289) | 0.340 |
关节受累 | 0.650 (0.289~1.463) | 0.298 |
心血管受累 | 0.440 (0.219~0.884) | 0.021 |
肾脏受累 | 1.051 (0.170~6.493) | 0.958 |
神经系统受累 | 0.867 (0.363~2.070) | 0.748 |
红细胞沉降率 | 0.424 (0.246~0.731) | 0.002 |
超敏C反应蛋白 | 0.459 (0.234~0.900) | 0.023 |
血红蛋白 | 1.003 (1.000~1.006) | 0.050 |
白细胞计数 | 1.052 (0.895~1.236) | 0.527 |
中性粒细胞计数 | 1.249 (1.039~1.501) | 0.018 |
血小板计数 | 0.994 (0.989~0.999) | 0.013 |
铁蛋白 | 0.999 (0.995~1.003) | 0.584 |
丙氨酸转氨酶 | 0.961 (0.924~1.000) | 0.049 |
肌酐 | 0.982(0.962~1.002) | 0.086 |
ANA | 1.183 (0.512~2.733) | 0.694 |
ANCA | 0.667 (0.236~1.884) | 0.444 |
Table 3
Multivariate Logistic regression analysis identified independent risk factors for airway involvement
项目 | OR(95%CI) | P |
---|---|---|
确诊年龄 | 1.097 (1.015~1.186) | 0.020 |
耳软骨受累 | 0.352 (0.159~0.780) | 0.010 |
眼部受累 | 0.401 (0.182~0.885) | 0.024 |
心血管受累 | 0.468 (0.219~0.999) | 0.049 |
红细胞沉降率 | 0.457 (0.251~0.832) | 0.010 |
超敏C反应蛋白 | 0.512 (0.245~1.069) | 0.074 |
中性粒细胞计数 | 1.215 (1.001~1.474) | 0.048 |
血小板计数 | 0.995 (0.990~1.001) | 0.082 |
丙氨酸转氨酶 | 0.971 (0.931~1.013) | 0.173 |
[1] |
Padoan R, Campaniello D, Iorio L, et al. Biologic therapy in relapsing polychondritis: navigating between options[J]. Expert Opin Biol Ther, 2022, 22(5):661-671.
doi: 10.1080/14712598.2022.2048647 pmid: 35230215 |
[2] | Cardoneanu A, Rezus II, Burlui AM, et al. Autoimmunity and autoinflammation: relapsing polychondritis and VEXAS syndrome challenge[J]. Int J Mol Sci, 2024, 25(4):2261. |
[3] | 徐健, 王丹丹, 石桂秀, 等. 复发性多软骨炎诊疗规范[J]. 中华内科杂志, 2022, 61(05):525-530. |
[4] | Dion J, Costedoat-Chalumeau N, Sène D, et al. Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients[J]. Arthritis Rheumatol, 2016, 68(12):2992-3001. |
[5] | Zhai SY, Guo RY, Zhang C, et al. Clinical analysis of relapsing polychondritis with airway involvement[J]. J Laryngol Otol, 2023, 137(1):96-100. |
[6] |
Jafarpour M, Saberivand M, Saemi M, et al. A multicenter study of long-term outcomes of relapsing polychondritis in Iran[J]. Sci Rep, 2024, 14(1):16486.
doi: 10.1038/s41598-024-67530-8 pmid: 39020004 |
[7] |
Damiani JM, Levine HL. Relapsing polychondritis—report of ten cases[J]. Laryngoscope, 1979, 89(6 Pt 1):929-946.
pmid: 449538 |
[8] | McAdam LP, O’Hanlan MA, Bluestone R, et al. Relapsing polychondritis: prospective study of 23 patients and a review of the literature[J]. Medicine (Baltimore), 1976, 55(3):193-215. |
[9] |
Mertz P, Costedoat-Chalumeau N, Ferrada MA, et al. Relapsing polychondritis: clinical updates and new differential diagnoses[J]. Nat Rev Rheumatol, 2024, 20(6):347-360.
doi: 10.1038/s41584-024-01113-9 pmid: 38698240 |
[10] | Liu Y, Cheng L, Zhao M, et al. Development and validation of diagnostic and activity-assessing models for relapsing polychondritis based on laboratory parameters[J]. Front Immunol, 2023, 14:1274677. |
[11] | Kuo IC, Hsieh CI, Lee YC, et al. Diagnostic challenges and management of relapsing polychondritis with large-airway involvement: a case series and literature review[J]. Life (Basel), 2024, 14(9):1194. |
[12] | 张海艇, 王立, 闫琳毅, 等. 复发性多软骨炎患者临床特征分析[J]. 中华医学杂志, 2015 (29): 2375-2378. |
[13] | Lin DF, Yang WQ, Zhang PP, et al. Clinical and prognostic characteristics of 158 cases of relapsing polychondritis in China and review of the literature[J]. Rheumatology international, 2016, 36: 1003-1009. |
[14] |
Rafeq S, Trentham D, Ernst A. Pulmonary manifestations of relapsing polychondritis[J]. Clin Chest Med, 2010, 31(3):513-518.
doi: 10.1016/j.ccm.2010.04.004 pmid: 20692543 |
[15] | de Montmollin N, Dusser D, Lorut C, et al. Tracheobronchial involvement of relapsing polychondritis[J]. Autoimmun Rev, 2019, 18(9):102353. |
[16] | Shimizu J, Yamano Y, Kawahata K, et al. Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics[J]. Medicine (Baltimore), 2018, 97(42):e12837. |
[17] | Yin R, Xu D, Wang Q, et al. Predictors and prognosis of tracheostomy in relapsing polychondritis[J]. Rheumatology (Oxford), 2024, 63(11):3042-3049. |
[18] |
Jalaber C, Puéchal X, Saab I, et al. Differentiating tracheobronchial involvement in granulomatosis with polyangiitis and relapsing polychondritis on chest CT: a cohort study[J]. Arthritis Res Ther, 2022, 24(1):241.
doi: 10.1186/s13075-022-02935-2 pmid: 36307863 |
[19] | Civan C, Işık EG, Has Şimşek D, et al. Diagnosis and evaluation of treatment response in relapsing polychondritis using 18F-FDG PET/CT[J]. Mol Imaging Radionucl Ther, 2024, 33(2):109-111. |
[20] |
Zhang L, Yun S, Wu T, et al. Clinical patterns and the evolution of relapsing polychondritis based on organ involvement: a Chinese retrospective cohort study[J]. Orphanet J Rare Dis, 2021, 16(1):225.
doi: 10.1186/s13023-021-01861-x pmid: 34001193 |
[21] | 蒋黎, 曹晓宇, 赵梦珠, 等. 呼吸道受累复发性多软骨炎患者的临床特点[J]. 中华临床免疫和变态反应杂志, 2021, 15(3):312-317. |
[22] | 刘禹. 哮喘气道中性粒细胞炎症表型的动态观察和临床意义研究[D]. 重庆: 第三军医大学, 2015. |
[1] | YUAN Xiaoya, ZHANG Keke, ZHU Zhenhang, CHENG Fang, ZHAO Futao. Clinical feature of primary Sjögren’s syndrome in elderly [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(06): 400-403. |
[2] | LI Lei, WU Xi, DAI Jing, WU Wenman, DING Qiulan, WANG Xuefeng. Clinical characteristics and risk factor analysis of 118 patients with cerebral venous sinus thrombosis [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(03): 261-269. |
[3] | LIN Xia, GAO Chao, HUANG Pei, WANG Gang, LIN Guozhen, REN Rujing. Analysis of clinical and imaging manifestations in 8 patients with MOGAG and literature review [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 606-612. |
[4] | HU Ying, BAO Yujie, BAI Yupan, LU Guanzhu, CHENG Yajiao, GUO Zhuying, XU Jie. Analysis of clinical and laboratory characteristics of EB virus infection in 67 adult patients [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(1): 74-79. |
[5] | SHI Dongmei, WANG Xiaolin, CHEN Lu, XIE Qing. Clinical characteristics and misdiagnosis analysis of sparganosis:A retrospective study of 52 cases [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(1): 37-43. |
[6] | WANG Juan, WANG Kaiwen, ZHAO Jiangfeng. Value of anti-melanoma differentiation-related gene 5 antibody for assessing disease activity and prognosis in patients with dermatomyositis-associated interstitial lung disease [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 155-159. |
[7] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(04): 214-218. |
[8] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(02): 99-104. |
[9] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(02): 65-70. |
[10] | LU Xiaoxue, DA Qian. Clinical characteristics and pathological features of Kimura disease: report of 13 case and review of literature [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 639-644. |
[11] | . [J]. Journal of Internal Medicine Concepts & Practice, 2015, 10(01): 29-34. |
[12] | . [J]. Journal of Diagnostics Concepts & Practice, 2014, 13(01): 49-53. |
[13] | . [J]. Journal of Internal Medicine Concepts & Practice, 2013, 8(02): 115-118. |
[14] | . [J]. Journal of Internal Medicine Concepts & Practice, 2011, 6(02): 140-142. |
[15] | . [J]. Journal of Internal Medicine Concepts & Practice, 2009, 4(04): 278-281. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||